"10.1371_journal.pmed.1000425","plos medicine","2011-03-15T00:00:00Z","Adriane Fugh-Berman; Christina Pike McDonald; Alicia M Bell; Emily Catherine Bethards; Anthony R Scialli","Department of Physiology and Biophysics, Georgetown University Medical Center, Washington D.C., United States of America; Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington D.C., United States of America","ICMJE criteria for authorship read and met: AFB CPM AMB ECB ARS. Agree with the manuscript's results and conclusions: AFB CPM AMB ECB ARS. Designed the experiments/the study: AFB CPM ECB ARS. Analyzed the data: AFB AMB ECB ARS. Collected data/did experiments for the study: CPM AMB ECB. Wrote the first draft of the paper: AFB. Contributed to the writing of the paper: CPM AMB ECB ARS.","Adriane Fugh-Berman directs PharmedOut (http://www.pharmedout.org/), a Georgetown University Medical Center project that educates physicians about inappropriate pharmaceutical marketing practices. Dr. Fugh-Berman is also a paid expert witness on behalf of women who developed breast cancer while taking menopausal hormone therapy. Alicia M. Bell was the paid project manager of PharmedOut during part of the time this study was conducted. Christina McDonald and Emily Catherine Bethards received graduate school credit for their work on this study while they were master's students in Physiology at Georgetown University Medical Center.","2011","03","Adriane Fugh-Berman","AFB",5,TRUE,NA,NA,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
